ABVC BioPharma, Inc. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ABVC BioPharma, Inc. (ABVC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 375.05 thousand shares for the 6-month period ending 2013-03-31, per its 10-Q filed 2015-04-16.
Discontinued › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2015-04-16
- ABVC BioPharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2012-12-31 was 375.05K shares, a 98.92% decline year-over-year.
- ABVC BioPharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2011-12-31 was 34.80M shares.
- ABVC BioPharma, Inc. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2011 was 34.80M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|
| 2013-03-31 | 375.05K shares 10-Q · filed 2015-04-16 | |||
| 2012-12-31 | 375.05K shares 10-Q · filed 2015-04-16 | |||
| 2012-09-30 | 34.80M shares 10-Q · filed 2015-04-16 | 375.05K shares 10-K · filed 2015-04-15 | ||
| 2011-12-31 | 34.80M shares 10-Q · filed 2015-04-16 | |||
| 2011-09-30 | 34.80M shares 10-K · filed 2015-04-15 |